Kevin Harrod, PhD

Kevin Harrod, PhD

University of Alabama at Birmingham

Research Project:
Novel SARS-CoV-2 antivirals targeting viral encoded ion channels

Grant Awarded:

  • COVID-19 Respiratory Virus Research Award

Research Topic:

  • combination therapies experimental therapeutics

Research Disease:

  • COVID-19

Despite the rapid deployment of vaccines that offer protective immunity, immunizations will not eradicate SARS-CoV-2, and break through infections will occur. Thus, therapeutic interventions and particularly antivirals will be critical in the postimmunization era of COVID-19. This application will use a high throughput drug screening platform to identify and repurpose already FDA approved drugs that may interfere with normal viral replication and could be used to blunt viral infections of the lung.

Page last updated: September 22, 2022

Clinical Trials: Why It's Important to Participate
, | Dec 14, 2023